Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
International Experimental Central Nervous System Injury & Repair (IECNSIR), Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine, University Hospital, Uppsala University, SE-75421 Uppsala, Sweden.
Hari S
HS
Sharma
Department of Clinical Neurosciences, University of Medicine & Pharmacy, Cluj-Napoca, Romania.|RoNeuro Institute for Neurological Research & Diagnostic, 37 Mircea Eliade Street, 400364 Cluj-Napoca, Romania.
Dafin F
DF
Muresanu
International Experimental Central Nervous System Injury & Repair (IECNSIR), Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine, University Hospital, Uppsala University, SE-75421 Uppsala, Sweden.
Aruna
A
Sharma
D000544:Alzheimer Disease / Q000188:drug therapy*; D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D036103:Nanotechnology; D018696:Neuroprotective Agents / Q000494:pharmacology*
D000596:Amino Acids; D018696:Neuroprotective Agents; C006952:cerebrolysin
Alzheimer's disease; AβP infusion; BBB leakage; brain pathology; cerebrolysin; diabetes; hypertension; military personnel; model; nanodelivery; neuroprotection; neurotrophic factors; post-traumatic stress disorder; traumatic brain injury